RxDoctor Payments Data

Simon Wright, MD

Otolaryngology · West Des Moines, IANPI 1710945506

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (48.1%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 32 manufacturers reported payments, led by Sanofi at 30.1% of the total. Reporting peaked in 2020 at $5,765 and has fallen 65.9% since, to $1,966 in 2025. Among otolaryngology clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$20,534in general payments, 2019–2025

Across 187 payments — averaging $109.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$6K
  • Regeneron Healthcare Solutions, Inc.$5K
  • Intuitive Surgical$4K
  • Medical Device Business Services, Inc.$1K
  • Intersect ENT, Inc.$1K
  • Aerin Medical Inc.$636
  • plus $3K from 26 others
$55,608in research payments, 2019–2025

Across 13 payments — averaging $4277.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • GSK$38K
  • Intersect ENT, Inc.$16K
  • Tactile Systems Technology Inc$1K

What the payments were for

  • Consulting fees$1501%
  • Speaking & faculty fees$9,87048%
  • Travel & lodging$5,30326%
  • Food & beverage$5,20725%
  • Gifts$40%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$20,534 in reported general payments places this provider in the 95th percentile of 103 otolaryngology providers in Iowa.

See all otolaryngology providers in Iowa

Medicare billing

Part B allowed, 2024
$266,467
Medicare patients
496
Services billed
1,865

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pantoprazole Sodium148$1,878
Famotidine89$1,009
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav18$312
Methylprednisolone29$178
Fluticasone Propionate23$165
Mupirocin23$132
Omeprazole13$111
Oxycodone Hcl44$99
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim11$82
Azithromycin19$36

Paid to pharmacies, not to this prescriber.

Other otolaryngology in West Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →